cancer

Antidepressant Paxil, commonly precribed for depressed cancer patients, increases risk of breast cancer

Monday, February 24, 2014 by: J. D. Heyes
Tags: antidepressants, Paxil, breast cancer

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Malaysia Airlines Flight 370 now clearly a government cover-up: All evidence contradicts official story
White House admits staging fake vaccination operation to gather DNA from the public
10 other companies that use the same Subway yoga mat chemical in their buns
High-dose vitamin C injections shown to annihilate cancer
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
U.S. treating meat with ammonia, bleach and antibiotics to kill the '24-hour sickness'
Ben and Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Battle for humanity nearly lost: global food supply deliberately engineered to end life, not nourish it
Diet soda, aspartame linked to premature deaths in women
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Cannabis kicks Lyme disease to the curb
Harvard research links fluoridated water to ADHD, mental disorders
Right to farm being stripped from Americans: Michigan to criminalize small family farms with chickens, goats, honey bees and more
Monsanto's seed imperialism halted in Canada thanks to massive protests
Delicious
(NaturalNews) New research suggests that one of the more popular antidepressants, Paxil, may actually contribute to the growth of cancerous tumors in women.

That's according to a team of scientists from the City of Hope in Duarte, California, which has developed a quick way to zero in on drugs and chemicals that are capable of disrupting human sex hormones and influencing the development and progression of diseases, like breast cancer in women.

As reported by the Los Angeles Times:

In a trial screening of 446 drugs in wide circulation, the new assay singled out the popular antidepressant paroxetine (better known by its commercial name, Paxil) as having a weak estrogenic effect that could promote the development and growth of breast tumors in women.

The finding is important because as much as 25 percent of women who are under treatment for breast cancer suffer from depression, and that's a condition regularly treated with antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, like Paxil (which has been on the market for 22 years).

Furthermore, the study showed, nearly a quarter of all women in the U.S. in their 40s and 50s are on some form of antidepressant, mostly SSRIs.

Other medications also have a similar negative effect on estrogen

The Times reported that, last summer, the U.S. Food and Drug Administration approved the marketing of a low-dose paroxetine, which has been repackaged under the trade name Brisdelle, as a treatment for hot flashes and other menopause-related problems that is also non-hormonal.

Some 70 percent of breast cancers in women are estrogen-sensitive, which means that a hormone found in abundance in childbearing-aged females actually contributes to the growth of cancerous tumors.

The unique screening method that was developed at City of Hope, which was detailed in an upcoming issue of the journal Toxicological Sciences, also identified a pair of antifungal drugs -- biconazole and oxyconazole -- as having a negative effect on estrogen that was similar to that of medications prescribed to prevent breast cancer and stop it from recurring in women. More from the Times:

Incidental to their intended use in combating fungal infections, those medications inhibit the action of aromatase, an enzyme that converts androgens -- hormones more plentiful in males but present in both sexes -- into estrogen.

Less surprising, the high-throughput screening mechanism identified bisphenol A -- a compound used in the manufacture of plastics and epoxy resins -- as an estrogen promoter capable of raising breast cancer risk.


The finding that Paxil has an endocrine-altering effect may provide insight to cancer researchers regarding their increased suspicions of medication in women with breast cancer. In 2010, for example, a study found that breast cancer patients in Canada who were prescribed Paxil were more likely than those who had been given a different antidepressant to die of breast cancer, "when there was a substantial overlap in their use of that antidepressant and of tamoxifen to prevent breast cancer recurrence," the Times reported.

The researchers believed that paroxetine -- taken by about one-fourth of cancer patients in the study who had been diagnosed with depression -- might block the production of a liver enzyme that scientists say is necessary to break down tamoxifen.

The authors of this latest study said that paroxetine's "weak estrogenic" effect "may be responsible, in part, for the observed reduction" in tamoxifen's effectiveness in the study.

As a class of drugs, SSRIs have proven to be quite controversial, as we have documented for years here at Natural News. Among the most controversial:

-- SSRIs have been linked to birth defects, complications during pregnancy and even miscarriages. "Big Pharma wants pregnant women to take prescription drugs, vaccine shots and even chemotherapy. It's the latest insanity from an industry that kills more Americans ever year than died in the entire Vietnam War. And the latest science reveals that antidepressant use during pregnancy is causing babies to be born with physical defects -- or sometimes not born at all because they're miscarried" [http://www.naturalnews.com].

-- Studies have shown that women who take SSRIs during pregnancy run a higher risk of developing pulmonary persistent hypertension (high blood pressure) [http://www.naturalnews.com].

-- And there is this: Studies suggest that SSRIs -- which are prescribed ostensibly to "treat" depression -- may lead to more suicides among patients taking them [http://www.naturalnews.com].

Sources:

http://www.latimes.com

http://www.naturalnews.com

http://science.naturalnews.com

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.